Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.

Saved in:
Bibliographic Details
Title: Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Authors: Pazdera L; Vestra Clinics, Rychnov nad Kneznou, Czech Republic., Sperling MR; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Harvey JH; Division of Epilepsy, Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, USA., Sam MC; Wake Forest School of Medicine, Winston Salem, NC, USA., Strom LA; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Blum D; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Grinnell T; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA., Cheng H; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA.
Source: Epilepsia [Epilepsia] 2018 Mar; Vol. 59 (3), pp. 704-714. Date of Electronic Publication: 2018 Feb 16.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-1167
DOI:10.1111/epi.14014